Literature DB >> 3988746

Differences in domain structure between human fibronectins isolated from plasma and from culture supernatants of normal and transformed fibroblasts. Studies with domain-specific antibodies.

K Sekiguchi, A Siri, L Zardi, S Hakomori.   

Abstract

The domain structure of human fibronectins isolated from plasma and from the conditioned medium of normal and transformed fibroblasts was analyzed by limited proteolysis and S-cyanylation followed by immunostaining of released fragments with five kinds of antibodies, each specific for one functional domain. The results indicate that all three human fibronectins are composed of the same set of functional domains aligned in the same topological order. However, the following clear differences were found in specific fragments released from plasma fibronectin (pFN) and those released from fibronectin of normal (N-cFN) and transformed fibroblasts (T-cFN). Two fragments (Mr = 70,000 and 60,000) were released from the COOH-terminal region of pFN by cathepsin D. These fragments represent the COOH-terminal heparin-binding (Hep-2) and fibrin-binding (Fib-2) domains. The corresponding fragments released from both N-cFN and T-cFN by cathepsin D had much larger molecular weights (Mr = 100,000 and 83,000-74,000) than those from pFN. The fragments from the Fib-2 domain alone, however, did not show any difference among all three FNs. The internal region, from the gelatin-binding (Gel) domain through the Hep-2 domain, of N-cFN and T-cFN was released as a Mr = 210,000 fragment upon mild trypsin digestion. The corresponding fragment from pFN was released as a Mr = 185,000 fragment. The COOH-terminal half, including the Hep-2 domain, of both N-cFN and T-cFN was released by S-cyanylation as Mr = 160,000-145,000 fragments, which are 25,000-20,000 larger than the corresponding fragments of pFN. These results clearly indicate that the Hep-2 domain of N-cFN and T-cFN is 30,000-20,000 daltons larger than the same domain of pFN. Although various fragments released from N-cFN and T-cFN showed a similar pattern, there were minor differences. Thermolysin fragments derived from the Hep-2 domain of N-cFN were clearly distinguishable from those from T-cFN. Three groups of fragments with Mr = 40,000, 35,000-32,000, and 30,000 were released from N-cFN, while only the 35,000-32,000 fragment was released from T-cFN. The Mr = 44,000/60,000 thermolysin fragments representing the Gel domain and the Mr = 210,000/165,000 tryptic fragments representing the internal domains of T-cFN were slightly, but consistently, larger than those of N-cFN.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3988746

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Human plasma fibronectin. Demonstration of structural differences between the A- and B-chains in the III CS region.

Authors:  T Tressel; J B McCarthy; J Calaycay; T D Lee; K Legesse; J E Shively; H Pande
Journal:  Biochem J       Date:  1991-03-15       Impact factor: 3.857

2.  Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process.

Authors:  Leonardo Freire-de-Lima; Kirill Gelfenbeyn; Yao Ding; Ulla Mandel; Henrik Clausen; Kazuko Handa; Sen-Itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

3.  Immunohistochemical localization of extracellular matrix in perivillous fibrinoid of normal human term placenta.

Authors:  A K Nanaev; A P Milovanov; S P Domogatsky
Journal:  Histochemistry       Date:  1993-11

Review 4.  Molecules that make axons grow.

Authors:  A D Lander
Journal:  Mol Neurobiol       Date:  1987       Impact factor: 5.590

5.  Analysis of splice variants of the fibronectin gene in thyroid carcinomas by reverse transcription-polymerase chain reaction: increased expression of oncofetal fibronectin mRNA in papillary carcinomas is not caused by the alternation in splicing.

Authors:  T Takano; F Matsuzuka; G Liu; A Miyauchi; T Yokozawa; K Kuma; N Amino
Journal:  J Endocrinol Invest       Date:  1999-01       Impact factor: 4.256

6.  Cell-type-specific expression of alternatively spliced human fibronectin IIICS mRNAs.

Authors:  R P Hershberger; L A Culp
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Anti-adhesive glycosylation of fibronectin-like molecules in human placental matrix-type fibrinoid.

Authors:  H G Frank; B Huppertz; S Kertschanska; D Blanchard; D Roelcke; P Kaufmann
Journal:  Histochem Cell Biol       Date:  1995-10       Impact factor: 4.304

8.  Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.

Authors:  H Lilja; J Oldbring; G Rannevik; C B Laurell
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

9.  Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells.

Authors:  P A Norton; R O Hynes
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

10.  The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.

Authors:  H Matsuura; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.